CNBX Pharmaceuticals (OTCMKTS:CNBX – Get Rating) is one of 346 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare CNBX Pharmaceuticals to similar businesses based on the strength of its earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends. Institutional and Insider Ownership 98.2% […]
/PRNewswire/ The "Global Ophthalmics Partnering 2016-2023: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com s offering..
/PRNewswire/ The "Global Ophthalmics Partnering 2014-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com s offering..
Cannabics Pharmaceuticals Inc. (OTCMKTS:CNBX – Get Rating) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 1,800 shares, a drop of 83.8% from the February 28th total of 11,100 shares. Based on an average daily trading volume, of 132,000 shares, the days-to-cover ratio […]